Current and Investigational Therapeutics for Fabry Disease

Fabry disease (FD) is an X-linked lysosomal storage disease caused by a deficiency in the lysosomal enzyme α-galactosidase (α-GAL). This in turn leads to the buildup of globotriaosylceramide, resulting classically in progressive kidney disease, peripheral neuropathy, early-onset cerebrovascular dise...

Descripción completa

Detalles Bibliográficos
Autores principales: Felis, Andrew, Whitlow, Michael, Kraus, Abigayle, Warnock, David G., Wallace, Eric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136345/
https://www.ncbi.nlm.nih.gov/pubmed/32274449
http://dx.doi.org/10.1016/j.ekir.2019.11.013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7136345/
https://www.ncbi.nlm.nih.gov/pubmed/32274449
http://dx.doi.org/10.1016/j.ekir.2019.11.013

Ejemplares similares